Michael A O'Donnell

Title: Michael A O'Donnell: Innovator in Protein Preservation and Vaccine Development

Introduction

Michael A O'Donnell is a notable inventor based in Sudbury, MA (US). He holds a total of 3 patents that reflect his contributions to the fields of protein preservation and vaccine development. His work has significant implications for clinical, therapeutic, and research applications.

Latest Patents

One of his latest patents is focused on a stabilizing formulation for preserving the integrity of proteins present in body fluid samples obtained ex-vivo. This invention provides stabilizing formulations that can be prepared as either a dry, anhydrous mixture of powders or as an aqueous-based liquid. These formulations are designed to maintain the integrity of proteins and polypeptides, making them suitable for various applications under different conditions. Another significant patent involves recombinant mycobacterial vaccines, particularly recombinant M. bovis BCG. This invention expresses heterologous DNA encoding a product of interest, such as an antigen, to elicit an immune response.

Career Highlights

Throughout his career, Michael has worked with prestigious institutions, including the Whitehead Institute for Biomedical Research and Beth Israel Deaconess Medical Center, Inc. His experience in these organizations has contributed to his innovative research and development efforts.

Collaborations

Michael has collaborated with notable colleagues, including Rosemary B Duda and William C DeWolf. Their combined expertise has likely enhanced the impact of his inventions.

Conclusion

Michael A O'Donnell's contributions to the fields of protein preservation and vaccine development demonstrate his innovative spirit and commitment to advancing medical science. His patents reflect a dedication to improving clinical and research methodologies.